MediciNova
MNOV
MediciNova (MNOV) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.05
- EPS estimate
- −$0.06
- EPS surprise
- +28.91%
- Revenue surprise
- +512.00%
- Revenue
- $459,000.00
- Revenue estimate
- $75,000.00
- Reported
- Aug 13, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | −$0.06 | −$0.05 | +28.91% | $459,000.00 | SEC |
| Q1 2026 | May 14, 2026 | −$0.08 | −$0.05 | +39.76% | $186,984.00 | SEC |
| Q4 2025 | Feb 20, 2026 | −$0.12 | −$0.06 | +50.00% | $151,000.00 | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.12 | −$0.12 | +0.00% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$0.10 | −$0.12 | −28.74% | $0.00 | SEC |
| Q1 2025 | May 13, 2025 | −$0.14 | −$0.06 | +57.14% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$0.06 | −$0.06 | +0.00% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.06 | −$0.05 | +16.67% | $0.00 | SEC |
| Q1 2024 | May 9, 2024 | −$0.05 | −$0.06 | −20.00% | $0.00 | SEC |
| Q4 2023 | Feb 15, 2024 | −$0.08 | −$0.08 | +0.00% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.08 | −$0.01 | +87.50% | $1.0M | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.07 | −$0.06 | +14.29% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$0.07 | −$0.06 | +14.29% | $0.00 | SEC |
| Q1 2022 | May 12, 2022 | −$0.08 | −$0.07 | +12.50% | $0.00 | — |
| Q2 2021 | Aug 12, 2021 | −$0.09 | −$0.09 | −3.81% | $0.00 | — |
| Q1 2021 | May 13, 2021 | −$0.08 | $0.00 | +100.00% | $4.0M | — |
| Q3 2020 | Oct 26, 2020 | −$0.12 | −$0.25 | −107.42% | $0.00 | — |
| Q1 2020 | Apr 23, 2020 | −$0.08 | −$0.06 | +25.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did MediciNova (MNOV) last report earnings?
MediciNova last reported on Aug 13, 2026, covering fiscal Q2 2026.
Did MNOV beat earnings estimates?
Yes. MediciNova reported EPS of −$0.05 for Q2 2026 against a −$0.06 estimate — a 28.91% beat.
How much revenue did MNOV report last quarter?
MediciNova reported $459,000.00 in revenue for Q2 2026, against a consensus estimate of $75,000.00.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.